OPHISTASIN Trademark

Trademark Overview

On Wednesday, August 12, 2009, a trademark application was filed for OPHISTASIN with the United States Patent and Trademark Office. The USPTO has given the OPHISTASIN trademark a serial number of 79074453. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, November 23, 2012. This trademark is owned by PENTAPHARM AG (PENTAPHARM Ltd). The OPHISTASIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used for diagnosing blood coagulation problems
ophistasin

General Information

Serial Number79074453
Word MarkOPHISTASIN
Filing DateWednesday, August 12, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, November 23, 2012
Registration Number3814798
Registration DateTuesday, July 6, 2010
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 20, 2010

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations used for diagnosing blood coagulation problems

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, November 23, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDSM IP Assets B.V.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNL
Party NameDSM IP Assets B.V.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNL
Party NameDSM IP Assets B.V.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressNL
Party NamePENTAPHARM AG (PENTAPHARM Ltd)
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressCH

Trademark Events

Event DateEvent Description
Saturday, June 22, 2013NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, June 22, 2013DEATH OF INTERNATIONAL REGISTRATION
Tuesday, January 8, 2013REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Monday, December 17, 2012PAPER RECEIVED
Tuesday, November 9, 2010FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, October 13, 2010FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, October 13, 2010FINAL DISPOSITION PROCESSED
Thursday, October 7, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 6, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, April 20, 2010PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2010NOTICE OF PUBLICATION
Tuesday, March 16, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 16, 2010ASSIGNED TO LIE
Wednesday, February 24, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 23, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 23, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 23, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 11, 2009REFUSAL PROCESSED BY IB
Saturday, November 21, 2009APPLICATION FILING RECEIPT MAILED
Thursday, November 19, 2009CHANGE OF OWNER RECEIVED FROM IB
Wednesday, November 18, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, November 18, 2009REFUSAL PROCESSED BY MPU
Wednesday, November 18, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 17, 2009NON-FINAL ACTION WRITTEN
Tuesday, November 17, 2009ASSIGNED TO EXAMINER
Tuesday, November 17, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 13, 2009LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, November 12, 2009SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

ophistasin coagulation problems blood diagnosing preparations used pharmaceutical